Study finds aspirin reduces risk of melanoma in women
- Posted: March 11, 2013
In the largest study ever to explore new ways to prevent melanoma, researchers at the Stanford University School of Medicine (home to the Stanford Cancer Institute) have discovered that women who took aspirin on a regular basis reduced their risk of developing this skin cancer. Results also showed that the longer women took aspirin, the lower their risk.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.